story
Developing test kits to diagnose Alzheimer’s disease
Developing test kits to diagnose Alzheimer’s disease We are pleased to announce our continued partnership with Apheon as our lead investor and partner investor MML. Apheon has reaffirmed its commitment to TMC by reinvesting with additional capital raised through an Apheon-controlled vehicle, ensuring long-term strategic alignment. Together, Apheon and MML will provide the capital and expertise to support TMC’s ambitious plans for strategic expansion and acquisitions.
Read more Read moreUpcoming events
Reach out for opportunities, collaborations, or questions. We're here to connect.